BETAHISTINE-ZP betahistine dihydrochloride 8mg tablets blister pack

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

betahistine dihydrochloride, Quantity: 8 mg

Pieejams no:

Medis Pharma Pty Ltd

SNN (starptautisko nepatentēto nosaukumu):

betahistine dihydrochloride

Zāļu forma:

Tablet

Kompozīcija:

Excipient Ingredients: stearic acid; crospovidone; colloidal anhydrous silica; povidone; lactose monohydrate; microcrystalline cellulose

Ievadīšanas:

Oral

Vienības iepakojumā:

100 tablets, 10 tablets, 25 tablets

Receptes veids:

(S4) Prescription Only Medicine

Ārstēšanas norādes:

Meniere?s Syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus

Produktu pārskats:

Visual Identification: White to almost white, round, flat bevelled edged tablets embossed B8 on one side and scored on the other; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Autorizācija statuss:

Licence status A

Autorizācija datums:

2015-11-10